Newsroom

Two researchers examine a Petri dish in the laboratory.
Story
The microbiome performs a variety of health-maintaining functions in the body. The microbes can produce nutrients, dampen inflammation or displace pathogens. In order to fulfill all these tasks, the microbiome must be in balance. For the microbiome, this means first and foremost that it is as diverse as possible. This makes it harder for harmful microorganisms to find a niche to live in. If microbiome diversity decreases or harmful germs dominate, there is a risk of inflammation, infections or chronic diseases - and this is precisely where the Helmholtz Centre for Infection Research (HZI) comes in. Using “microbiome engineering”, Dr. Lisa Osbelt-Block and Prof. Till Strowig are specifically editing the gut microbiome to prevent disease.
19.02.2026
Dzanga-Sangha Protected Areas
Story
On 18–20 November 2025, the Central African Republic (CAR) celebrated its first-ever Dzanga-Sangha Day (La Journée des Aires Protégées de Dzanga-Sangha). Conceived as a three-day national event, the celebration aimed to shine a spotlight on the country’s unique natural heritage and raise awareness of the Dzanga-Sangha Protected Areas (DSPA)—an extraordinary conservation landscape in CAR’s remote southwest. Held under the theme “Reconciling Nature, Health and Development”, the event underscored how biodiversity protection, community wellbeing, and scientific research intersect in DSPA. It was co-organized by the Government of the Central African Republic in partnership with WWF and the Helmholtz Institute for One Health (HIOH).
03.12.2025
[Translate to English:] Rasterelektronenmikroskopische Aufnahme einer Escherichia coli-Zelle (rot), die von Bakteriophagen (grün) infiziert wird.
Story
Since the middle of the 20th century, antibiotics have been among the greatest successes in medicine. They save millions of lives every year, prevent complications during operations and make many therapies possible in the first place. But their success has a downside: More and more bacteria are developing strategies to evade the attacks of these drugs. Resistant germs are spreading around the globe, against which hardly any drugs are effective. With the annual World Antimicrobial Resistance Awareness Week (WAAW) from 18 to 24 November, the World Health Organization reminds us how important it is to use antibiotics carefully and how urgently new approaches are needed to continue fighting infections effectively in the future. Almost 20 research groups in the research topic “Novel Anti-Infectives” at the Helmholtz Centre for Infection Research (HZI) are developing new drugs against infectious diseases.
17.11.2025
[Translate to English:] Empfangsschild des Arabuko-Sokoke-Nationalparks
Story
Natural substances are an important source of active ingredients used in medicine. However, the chemical diversity of fungi in particular has not yet been sufficiently researched. The EU project Mycobiomics, coordinated by Marc Stadler, Head of the Department “Microbial Drugs” at the Helmholtz Centre for Infection Research (HZI), is investigating the biodiversity of fungi in Europe, Asia and Africa in order to identify pharmaceutically valuable secondary metabolites. In May and June 2025, project participants met in Kenya and South Africa for an expedition and a subsequent symposium.
09.07.2025
Preparing for historical specimen sampling
Story
From 4 to 6 June 2025, the Department “Pathogen Evolution” led by Prof. Dr. Sébastien Calvignac-Spencer at the Helmholtz Institute for One Health (HIOH) conducted a combined retreat and sampling mission at the Institute of Pathology of the University of Veterinary Medicine Vienna — a key collaboration partner for accessing and studying historical pathological specimens in veterinary medicine. HIOH is a site of the Helmholtz Centre for Infection Research (HZI). The visit focused on collecting around 60 historical tissue samples for molecular genetic analyses related to animal disease research, while also offering time for internal discussions on lab optimization, project development, and team building.
03.07.2025
Group photo with 14 persons
Story
The Republic of Côte d'Ivoire is a vibrant country in West Africa with rich cultural traditions and diverse ecosystems. Despite its beauty and vitality, the country faces significant challenges in its health system, particularly with regard to infectious diseases and antimicrobial resistance (AMR). These challenges are exacerbated by limited healthcare expenditure, which remains among the lowest in the world. Infectious diseases, the risk of zoonotic transmission (i.e., infectious diseases that can spread from animals to humans) and the high burden of healthcare-associated infections pose serious public health problems and make Côte d'Ivoire a priority country for international health cooperation.
03.02.2025

HZI in the media

says Livia Patrono, a veterinarian and disease ecologist at Helmholtz Institute for One Health in Greifswald, Germany. In 2012, an infected

24.02.2026
|
Science News

... Dr. rer. nat. Jakob Wirbel vom Helmholtz-Zentrum für Infektionsforschung (Braunschweig). Das Experiment aus Stanford sei ...

20.02.2026
|
Deutsches Ärzteblatt

... unseres Immunsystems zu entziehen. Strukturbiologen des Helmholtz-Zentrums für Infektionsforschung (HZI) konnten nun mittels ...

18.02.2026
|
Bionity.COM

of our immune system. Structural biologists at the Helmholtz Center for Infection Research (HZI) have now used cryo-electron microscopy to

16.02.2026
|
Phys.org

Was es mit Mpox – früher Affenpocken genannt – auf sich hat, welche Symptome erkrankte Personen haben und wie man sich anstecken kann.

13.02.2026
|
Apotheken Umschau

Julia Port, research group leader at Germany's Helmholtz Center for Infection Research.

 

"Ongoing outbreaks—particularly those driven by

12.02.2026
|
Medical Xpress

... Livia Patrono, laut einer Mitteilung des beteiligten Helmholtz-Instituts für One Health (HIOH): Denn dadurch ...

12.02.2026
|
n-tv

... für den Neubau der Klinik für Strahlentherapie Würzburg sowie für das Helmholtz-Institut für RNA-basierte ...

12.02.2026
|
Main-Post - Karlstadt

Project

 

Researchers at the Helmholtz Institute for One Health (HIOH), a site of the Helmholtz Centre for Infection Research (HZI), together

11.02.2026
|
NewsBreak

by Prof. Hortense Slevogt, Hannover Medical School, and Helmholtz Centre for Infection Research, shows that the treatment with PulmoPlas®

10.02.2026
|
Biotech Investments

... der Medizinischen Hochschule Hannover und des Helmholtz-Zentrums für Infektionsforschung. „Unsere Methode erfordert nur einen ...

10.02.2026
|
Health Capital

Fermentation und Aufreinigung, wurde ebenfalls am HZI in der Arbeitsgruppe von Prof. Marc Stadler, stellvertretender ...

06.02.2026
|
juraforum.de

Register now for the HZI-Newsletter